Astex Pharmaceuticals, Inc.   Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Cambridge United Kingdom (1999)
Status: Acquired by Otsuka (2013)

Organization Overview

First Clinical Trial
1999
NCT00005869
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Astex Pharmaceuticals | Astex Pharmaceuticals, Inc. | Astex Therapeutics | Astex Therapeutics (v2)